Showing results (631-640 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|June 2, 2026
Cost-Effectiveness and Budget-Impact Analysis of Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity in the German Health-Care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.Pharmacoeconomics|June 2, 2026
A Systematic Literature Review of Health Economic Modelling Approaches Used to Evaluate Treatment Resistant and Uncontrolled Hypertension: A Critical Appraisal and Considerations for the Design of Future Model AnalysesMatthew Franklin, James Fotheringham, Rod S Taylor, et al.Pharmacoeconomics|October 21, 2021
The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic ConditionsYan Meng, Philip M Clarke, Ilias GoranitisPharmacoeconomics|November 29, 2002
Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study durationMartin E BackhousePharmacoeconomics|February 1, 2003
A meta-analysis of quality-of-life estimates for strokeTammy O Tengs, Ting H LinPharmacoeconomics|July 18, 2001
Developing guidance for budget impact analysisP Trueman, M Drummond, J HuttonPharmacoeconomics|January 31, 2002
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitisPhilippe Beutels, W John Edmunds, Fernando Antoñanzas, et al.Pharmacoeconomics|April 13, 2002
Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UKPeter Wahlqvist, Ola Junghard, Andy Higgins, et al.Pharmacoeconomics|June 24, 2004
Cost effectiveness and cost utility of adjuvant interferon alpha in cutaneous melanoma: a reviewRalph CrottPharmacoeconomics|September 28, 2006
The generalisability of pharmacoeconomic studies: issues and challenges aheadJames M Mason, Anne R MasonPageof 335